267 related articles for article (PubMed ID: 37298160)
1. Markers of NETosis in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome.
Reshetnyak T; Nurbaeva K; Ptashnik I; Kudriaeva A; Belogurov A; Lila A; Nasonov E
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298160
[TBL] [Abstract][Full Text] [Related]
2. [NETosis in lupus nephritis].
Reshetnyak TM; Nurbaeva KS; Ptashnik IV; Kudrieva AA; Belogurov AA; Lila AM; Nasonov EL
Ter Arkh; 2024 Jun; 96(5):453-458. PubMed ID: 38829805
[TBL] [Abstract][Full Text] [Related]
3. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.
Ramos-Casals M; Campoamor MT; Chamorro A; Salvador G; Segura S; Botero JC; Yagüe J; Cervera R; Ingelmo M; Font J
Lupus; 2004; 13(10):777-83. PubMed ID: 15540510
[TBL] [Abstract][Full Text] [Related]
4. Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis.
Bruschi M; Moroni G; Sinico RA; Franceschini F; Fredi M; Vaglio A; Cavagna L; Petretto A; Pratesi F; Migliorini P; Locatelli F; Pazzola G; Pesce G; Bagnasco M; Manfredi A; Ramirez GA; Esposito P; Murdaca G; Negrini S; Cipriani L; Trezzi B; Emmi G; Cavazzana I; Binda V; Fenaroli P; Pisani I; Garibotto G; Montecucco C; Santoro D; Scolari F; Mosca M; Tincani A; Candiano G; Prunotto M; Volpi S; Verrina E; Angeletti A; Ravelli A; Ghiggeri GM
Rheumatology (Oxford); 2021 Jul; 60(7):3176-3188. PubMed ID: 33374003
[TBL] [Abstract][Full Text] [Related]
5. IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus.
Reshetnyak T; Cheldieva F; Cherkasova M; Lila A; Nasonov E
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012697
[TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid syndrome damage index (DIAPS): distinct long-term kinetic in primary antiphospholipid syndrome and antiphospholipid syndrome related to systemic lupus erythematosus.
Torricelli AK; Ugolini-Lopes MR; Bonfá E; Andrade D
Lupus; 2020 Mar; 29(3):256-262. PubMed ID: 31986962
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil extracellular traps-associated markers are elevated in patients with systemic lupus erythematosus.
Jeremic I; Djuric O; Nikolic M; Vlajnic M; Nikolic A; Radojkovic D; Bonaci-Nikolic B
Rheumatol Int; 2019 Nov; 39(11):1849-1857. PubMed ID: 31444555
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
[TBL] [Abstract][Full Text] [Related]
9. Splicing machinery is profoundly altered in systemic lupus erythematosus and antiphospholipid syndrome and directly linked to key clinical features.
Lopez-Pedrera C; Patiño-Trives AM; Cerdó T; Ortega-Castro R; Sanchez-Pareja I; Ibañez-Costa A; Muñoz-Barrera L; Ábalos-Aguilera MC; Ruiz-Vilchez D; Seguí Azpilcueta P; Espinosa M; Barbarroja N; Escudero-Contreras A; Castaño JP; Luque RM; Ortega R; Aguirre MA; Perez-Sanchez C
J Autoimmun; 2023 Feb; 135():102990. PubMed ID: 36621176
[TBL] [Abstract][Full Text] [Related]
10. Distinct antibody profile: a clue to primary antiphospholipid syndrome evolving into systemic lupus erythematosus?
Freire PV; Watanabe E; dos Santos NR; Bueno C; Bonfá E; de Carvalho JF
Clin Rheumatol; 2014 Mar; 33(3):349-53. PubMed ID: 24420722
[TBL] [Abstract][Full Text] [Related]
11. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
[TBL] [Abstract][Full Text] [Related]
12. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.
Tarr T; Lakos G; Bhattoa HP; Szegedi G; Shoenfeld Y; Kiss E
Lupus; 2007; 16(5):324-8. PubMed ID: 17576733
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I
Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
[TBL] [Abstract][Full Text] [Related]
14. [Systemic lupus erythematosus and antiphospholipid syndrome - diagnostic and therapeutic problems].
Zdrojewski Z
Wiad Lek; 2018; 71(1 pt 1):40-46. PubMed ID: 29558350
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
16. [The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases].
Quattrocchi P; Barrile A; Bonanno D; Giannetto L; Patafi M; Tigano V; Ferlazzo B
Reumatismo; 2005; 57(2):109-13. PubMed ID: 15983634
[TBL] [Abstract][Full Text] [Related]
17. The behavior of neutrophil extracellular traps and NADPH oxidative activity in pediatric systemic lupus erythematosus: relation to disease activity and lupus nephritis.
El-Ghoneimy DH; Hesham M; Hasan R; Tarif M; Gouda S
Clin Rheumatol; 2019 Sep; 38(9):2585-2593. PubMed ID: 31030361
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
Cabiedes J; Cabral AR; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
[TBL] [Abstract][Full Text] [Related]
19. Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up.
Gerhardsson J; Sundelin B; Zickert A; Padyukov L; Svenungsson E; Gunnarsson I
Arthritis Res Ther; 2015 Apr; 17(1):109. PubMed ID: 25927214
[TBL] [Abstract][Full Text] [Related]
20. Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: Analysis of a cohort of 214 patients.
Paule R; Morel N; Le Guern V; Fredi M; Coutte L; Belhocine M; Mouthon L; le Jeunne C; Chauvin A; Piette JC; Costedoat-Chalumeau N
Autoimmun Rev; 2018 Sep; 17(9):866-872. PubMed ID: 30005859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
